Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Source
    • Language
455 result(s) for "Conte, V"
Sort by:
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
A series of 133 patients with severe heart failure underwent implantation of a continuous-flow left ventricular assist device. At 6 months, 75% of the patients had undergone heart transplantation, had cardiac recovery with device explantation, or continued to receive device support without any contraindication to subsequent transplantation. Important adverse events included postoperative bleeding, stroke, heart failure, and drive-line infection. A series of 133 patients with severe heart failure underwent implantation of a continuous-flow left ventricular assist device. At 6 months, 75% of the patients had undergone heart transplantation, had cardiac recovery, or continued to receive device support without any contraindication to subsequent transplantation. Therapy with a left ventricular assist device is an established form of treatment for patients with refractory heart failure. 1 In the United States, most patients undergoing implantation of such a device as a bridge to heart transplantation have received support from pulsatile volume-displacement devices that fill with and eject blood in a cyclic fashion that is analogous to the systole and diastole of the native heart. 2 – 7 These devices provide excellent hemodynamic support and improve survival but have substantial constraints, including the need for extensive surgical dissection, the requirement that the recipient have a large body habitus, the presence of . . .
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
This comparative-effectiveness trial assessed clinical outcomes in patients with advanced heart failure who were not candidates for cardiac transplantation and who had a continuous-flow left ventricular assist device as compared with a pulsatile-flow device. The continuous-flow device resulted in better clinical outcomes, but it has not yet been approved by the Food and Drug Administration. This comparative-effectiveness trial assessed clinical outcomes in patients with advanced heart failure who had a continuous-flow left ventricular assist device as compared with a pulsatile-flow device. The continuous-flow device resulted in better clinical outcomes. Medical and electrical therapies for systolic heart failure have improved outcomes and altered the natural history of the disease. 1 – 9 However, heart failure commonly progresses and becomes refractory to current treatments. Continuous intravenous inotropic support may improve clinical status in the short term but results in a survival rate at 1 year of only 10 to 30%. 10 , 11 Cardiac transplantation is available for only a minority of patients, because of a lack of suitable donor hearts. The paucity of effective therapies for advanced heart failure led to the evaluation of mechanical circulatory-support devices as permanent therapy. To date, only two . . .
Towards a compact experimental setup for gas-based microdosimetry
Microdosimetry measures the stochastics of imparted energy at the micrometre scale, and is a reliable experimental technique to monitor complex radiation fields such as those used in hadron therapy. At the Legnaro National Laboratories of INFN, miniaturized gas-based microdosimeters were developed specifically for this kind of applications. However, their use outside research facilities has been hindered by the encumbrance of the gas-flow system which is used to preserve gas purity and of the high-resolution analog electronic chain. To overcome this drawback, a new detector designed to work without gas flow was developed recently. The stability and reproducibility of its response in sealed conditions were studied in two measuring shifts one year apart from each other, both with the analog electronic chain and with a compact digital acquisition system. Preliminary results confirm the possibility to operate the detector with a very compact experimental setup, which could be a major advantage in clinical facilities.
An Avalanche confinement TEPC as connecting bridge from micro to nanodosimetry
It is recognized today that the observable radiobiological effects of ionizing radiations are strongly correlated to the clustering of damages in micrometer- and nanometer-sized subcellular structures, hence to the particle track structure. The characteristic properties of track structure are directly measurable nowadays with bulky experimental apparatuses, which cannot be easily operated in a clinical environment. It is therefore interesting to investigate the feasibility of new portable detectors able to characterize the real therapeutic beams. With this in mind, a novel avalanche-confinement Tissue Equivalent Proportional Counter (TEPC) was constructed for simulating nanometric sites down to 25 nm. Experimental cluster size distributions measured with this TEPC were compared with Monte Carlo simulations of the same experiment and with cluster size distributions measured with the Startrack nanodosimeter.
Mini-TEPC Microdosimetric Study of Carbon Ion Therapeutic Beams at CNAO
Mono-energetic carbon ion scanning beams of 195.2 MeV/u at the Italian National Centre for Oncological Hadrontherapy (CNAO) have been used to study the microdosimetric features of an “active” carbon ion beam used in hadrontherapy. A 30x30 mm2 area has been scanned by a 6 mm beam with scanning steps of 2 mm. A mini TEPC of 0.57 mm3 has been used to perform measurements in a water phantom at different depths on the beam axis. The detector small size allowed for measuring, with good spatial resolution, also inside the relatively small Bragg peak region and inside the distal edge, where the radiation quality varies quickly. In spite of the high event rate (up to ~ 105 s-1), no pile-up effects were observed. Results showed that the frequency-mean lineal energy scaled well with the absorbed dose. Moreover, the dose-mean lineal energy itself seemed to be a good descriptor of the radiation quality.
Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study
Bronchiolitis obliterans syndrome remains the leading cause of morbidity and mortality in the pulmonary transplant population. Previous studies show that macrolide antibiotics may be efficacious in the treatment of panbronchiolitis and cystic fibrosis. In the latter, azithromycin decreases the number of respiratory exacerbations, improves FEV1, and improves quality of life. We hypothesized that oral azithromycin therapy may improve lung function in patients with bronchiolitis obliterans syndrome. To test this hypothesis, we conducted an open-label pilot trial using maintenance azithromycin therapy in six lung transplant recipients (250 mg orally three times per week for a mean of 13.7 weeks). In this study, five of these six individuals demonstrated significant improvement in pulmonary function, as assessed by FEV1, as compared with their baseline values at the start of azithromycin therapy. The mean increase in the percentage of predicted FEV1 values in these individuals was 17.1% (p
Microdosimetry at the 62 MeV Proton Beam of CATANA: preliminary comparison of three detectors
A microdosimetric characterization of the 62 MeV proton beam line of CATANA has been performed all along the Spread Out Bragg Peak with three different detectors. Two silicon detectors and a Tissue Equivalent Proportional Counter measured at approximately the same depths of the SOBP. The TEPC is a new miniaturized gas counter developed at the Legnaro National Laboratories of INFN, modified to work without gas flow. The first silicon detector has been developed at the Politecnico of Milano and it is a monolithic telescope composed by a matrix of 2 µm thick cylindrical diodes with a diameter 9 µm. that compose the ΔE layer. The E and ΔE layers are fabricated on a single substrate of silicon. The third detector is the MicroPlus probe developed at the CMRP - University of Wollongong, it is an array of 3D sensitive volumes each with dimension 30x30 µm and 10 µm thick fabricated on SOI. Measurements performed with the three detectors are presented and discussed.
Off-pump coronary artery bypass in octogenarians: results of a statewide, matched comparison
Objectives Off-pump coronary artery bypass grafting (OPCAB) may have advantages in the elderly. Although proven safe, it remains unclear whether OPCAB provides a short-term survival benefit in octogenarians. We sought to compare outcomes using propensity matching between OPCAB and conventional surgery in a statewide database. Methods We identified all octogenarians (≥ 80 years) who underwent isolated coronary artery bypass grafting (CAB) at 10 different centers in the state of Maryland from July 2011 to June 2016. We separated patients into two groups: OPCAB and on-pump coronary artery bypass (ONCAB). Patients were assigned propensity scores with a semi-parsimonious logistic regression model and matched 1:1 by the nearest-neighbor principle. A revascularization ratio was determined between the number of distal grafts sewn and number of diseased coronaries (≥ 50% stenosis). Results In total, 926 octogenarians underwent isolated CAB (8.2% of all CAB): 798 (86%) had ONCAB and 128 (14%) had OPCAB. Propensity matching yielded 128 well-matched pairs. Operative mortality was similar between groups (OPCAB 5.5% vs ONCAB 3.1%, p  = 0.364). Rates of complications were similar between groups. OPCAB patients had a lower revascularization ratio (0.92 vs 1.15, p  < 0.001), but more frequent use of left internal mammary artery (97 vs 89%, p  = 0.017), and decreased intraoperative transfusion rates (33 vs 63%, p  < 0.001). Conclusions In comparing outcomes among octogenarians across the state of Maryland, OPCAB and ONCAB had similar mortality and morbidity. However, OPCAB was associated with a lower revascularization ratio. Thus, our results demonstrate no short-term survival benefit of OPCAB over ONCAB in octogenarians.
Microdosimetry on nanometric scale with a new low-pressure avalanche-confinement TEPC
The tissue equivalent proportional counter (TEPC) is the most accurate device for measuring the microdosimetric properties of a particle beam, nevertheless no detailed information on the track structure of the impinging particles can be obtained, since the lower operation limit of common TEPCs is about 0.3 μm. On the other hand, the pattern of particle interactions is measured by track-nanodosimetry, which derives the single-event distribution of ionization cluster size at the nanometric scale. Anyway, only three nanodosimeters are available worldwide. A feasibility study for extending the performances of TEPC down to the nanometric region was performed and a novel avalanche-confinement TEPC was designed and constructed. This detector is constituted by a cylindrical chamber, based on a three-electrode structure, connected to a vacuum and gas flow system to ensure a continuous replacement of the tissue equivalent gas, thus allowing to simulate different biological site sizes in the range 300-25 nm. This TEPC can be calibrated by exploiting a built-in alpha source and a miniaturized solid-state detector as a trigger. Irradiations with photons, fast neutrons and two hadron beams demonstrated the good performances of the device. A satisfactory agreement with FLUKA simulations was obtained.
Attributable harm of severe bleeding after cardiac surgery in hemodynamically stable patients
Background We sought to quantify the effect of severe postoperative bleeding in hemodynamically stable patients following cardiac surgery. Methods We reviewed the charts of all cardiac surgery patients operated on at our institution between 2010 and 2014. After excluding patients with tamponade or MAP <60, we propensity matched patients having chest tube output >300 mL in the first postoperative hour, >200 mL in the second, and >100 mL in the third (“bleeding” group) with patients having <50 mL/h of chest tube output (“dry” group). The primary outcome was a composite of morbidity or mortality (excluding reexploration). Results 5016 patients were operated on between 2010 and 2014; of these, we included the records of 84 bleeding and 498 dry patients. Propensity matching resulted in 68 pairs of patients well-matched on baseline and operative variables. As compared to matched dry patients, bleeding patients were more likely to experience the primary outcome of any morbidity/mortality (36.8 vs. 13.2 %, p  = 0.002), as well as ventilation >24 h (33.8 vs. 7.4 %, p  < 0.001) and 30-day mortality (11.8 vs. 1.5 %, p  = 0.02). Of the 84 bleeding patients, 46 underwent reexploration for bleeding within 24 h of surgery. A subgroup analysis propensity matching bleeding patients who were or were not reexplored <24 h demonstrated similarly poor outcomes in each group (primary outcome, 44.7 % reexplored vs. 50.0 % non-reexplored, p  = 0.65), though reexplored patients were far less likely to require hematoma evacuation/washout >24 h after surgery (0 vs. 18.4 %, p  = 0.005). Conclusions Even among hemodynamically stable patients, severe bleeding is associated with markedly worse outcomes following cardiac surgery.